Cargando…
A Robust 8-Gene Prognostic Signature for Early-Stage Non-small Cell Lung Cancer
Background: The current staging system is imprecise for prognostic prediction of early-stage non–small cell lung cancer (NSCLC). This study aimed to develop a robust prognostic signature for early-stage NSCLC, allowing classification of patients with a high risk of poor outcome and specific treatmen...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6684755/ https://www.ncbi.nlm.nih.gov/pubmed/31417870 http://dx.doi.org/10.3389/fonc.2019.00693 |